Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

330.87
+14.784.68%
Post-market: 335.004.13+1.25%18:13 EDT
Volume:1.35M
Turnover:445.69M
Market Cap:43.71B
PE:142.00
High:332.48
Open:319.06
Low:318.37
Close:316.09
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:1.17
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.33
EPS(LYR):2.33
ROE:73.28%
ROA:6.81%
PB:55.39
PE(LYR):142.00

Loading ...

Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments

Reuters
·
Mar 05

BRIEF-Tenaya Therapeutics Enters Into Research Collaboration With Alnylam Pharmaceuticals To Identify And Validate Novel Genetic Targets For Cardiovascular Disease Therapeutics

Reuters
·
Mar 05

Tenaya Therapeutics Inc - Co to Validate up to 15 Gene Targets Under Agreement

THOMSON REUTERS
·
Mar 05

Tenaya Therapeutics Enters Into Research Collaboration With Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics

THOMSON REUTERS
·
Mar 05

Tenaya Therapeutics Inc - to Receive up to $10 Mln Upfront and up to $1.13 Bln in Milestone Payments

THOMSON REUTERS
·
Mar 05

Alnylam CSO and EVP Head of Research Kevin Joseph Fitzgerald Disposes of Common Shares

Reuters
·
Mar 05

Alnylam grants CEO Yvonne Greenstreet $18 million performance-based equity award

Reuters
·
Mar 05

Alnylam EVP Chief R&D Pushkal Garg Disposes of Common Shares

Reuters
·
Mar 03

Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors

TIPRANKS
·
Mar 03

BRIEF-Alnylam Pharmaceuticals Receives Positive Recommendation From Canada's Drug Agency For Public Reimbursement Of Amvuttra

Reuters
·
Mar 02

Alnylam Pharmaceuticals: Receives Positive Recommendation From Canada's Drug Agency for Public Reimbursement of Amvuttra

THOMSON REUTERS
·
Mar 02

Reassessing Alnylam Pharmaceuticals (ALNY) After Recent Share Price Weakness

Simply Wall St.
·
Feb 26

Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 23

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After First Profitable Year And Rapid Revenue Growth

Simply Wall St.
·
Feb 20

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2026-02-19

Reuters
·
Feb 20

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 19

Tarsus Pharmaceuticals Names Former Allergan CEO David Pyott to Board

Reuters
·
Feb 18

Alnylam’s First Profitable Year Tests Durability Of TTR RNAi Franchise

Simply Wall St.
·
Feb 18

Alnylam CFO Jeffrey V. Poulton Reports Sale of Common Shares

Reuters
·
Feb 18

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-02-17

Reuters
·
Feb 18